Project description
Building an interconnected ecosystem for the biopharmaceutical sector
Industry 4.0 is considered the golden ticket to automation and data technologies. Powered by the internet of things, it has sent tremors across a wide range of industries. Many are trying to make a quick transition to Industry 4.0 in order to enjoy its benefits. Unfortunately, the transition is difficult due to high costs, a lack of work skills and other challenges. The EU-funded COBIOE project will develop an interconnected ecosystem to encourage actors in the biopharmaceutical sector to transition to Industry 4.0. It will collaborate with actors across the bioproduction value chains in Europe to foster improved communication and focus on green and digital technologies that can enhance cooperation and efficiency.
Objective
COBIOE is project to interconnect innovation ecosystems to foster 4.0 industrial transition in the biopharmaceutical deeptech sector, sharing competences, information and opportunities, with the aim of ultimately converging toward a common and inclusive European strategy for bioproduction support. Specifically, the proposition will focus on the bioproduction sector that includes development of small molecules, biologics, drugs, innovative therapeutics (such as gene and cellular therapies), high technology drugs based on cell and molecular biology, and covers various applications in health (oncology, immunology, virology, rare diseases, etc…).
COBIOE will reach the following objectives:
- Provide a state of the art and exploitable overview of the European bioproduction value chain, focusing on European, national, regional strategy or existing initiatives, activities
- Opening up the bioproduction field, by reaching out to isolated actors and territories bringing added value to the chain.
- Building up bridges between sparse innovative ecosystems and initiatives opening up opportunities for isolated players.
- Promote bioproduction ecosystems, the field and its potentialities in terms of green, digital and social transition, among various stakeholders and policymakers
COBIOE proposal includes 5 health clusters/networks, preeminent and pioneers in the field of pharmaceutical biomanufacturing. Each partner complements each other in terms of competence and the partnership covers almost all European regions from north to south and east to west, including modest, moderate, strong and leading innovators. Moreover, each partner benefits from an extended network of stakeholders, from different technological sectors (materials science, artificial intelligence, biotechnology, blockchain, robotics, photonics, electronics and quantum information) and actors (universities, research, hospitals, funders…).
Fields of science
- natural sciencescomputer and information sciencesartificial intelligence
- natural sciencesbiological sciencesmicrobiologyvirology
- natural sciencescomputer and information sciencescomputer securitycryptography
- engineering and technologyelectrical engineering, electronic engineering, information engineeringelectronic engineeringrobotics
- natural sciencesbiological sciencesmolecular biology
Keywords
Programme(s)
Funding Scheme
HORIZON-CSA - HORIZON Coordination and Support ActionsCoordinator
91030 Evry
France
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.